Concepedia

Duane Snavely

DS

Statistics

Publications

33

Citations

5.8K

H-Index

26

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Henry Ford Hospital

St. Luke's Hospital

Duke University

Duane Snavely is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacotherapy, and medicine.

Publications per year

1994–2020

33

Publications

33

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

Bertram Pitt, Robert Segal, Felipe A Martinez et al. · The Lancet · 1997 · 1.7K citations

, , +13

Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

Mark S. Kramer, Neal R. Cutler, John P. Feighner et al. · Science · 1998 · 1.1K citations

, , +17

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

David Michelson, Ellen Snyder, Erin M. Paradis et al. · The Lancet Neurology · 2014 · 509 citations

, , +12

Orexin receptor antagonism for treatment of insomnia

W. Joseph Herring, Ellen Snyder, Kerry Budd et al. · Neurology · 2012 · 319 citations

, , +17

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

W. Joseph Herring, Kathryn M. Connor, Neely Ivgy-May et al. · Biological Psychiatry · 2014 · 292 citations

, , +10

1–5 of 33